Barry Pupkin leads the firm’s Antitrust, Competition & International Trade Practice Group. Barry practices primarily before the Federal Trade Commission and the US Department of Justice, as well as other regulatory and legislative bodies including the Merger Task Force of the European Commission, US Congress and the Food and Drug Administration. Barry has been listed in the three most recent editions of the Guide to the World’s Leading Competition and Antitrust Lawyers.

His work includes representing clients in domestic and international business combinations including mergers, acquisitions, joint ventures and strategic alliances.

Barry’s experience includes antitrust and general regulatory counseling, compliance and litigation on diverse issues including advertising, trade association activities, competitive relationships, regulatory agency investigations, distribution, exclusive dealing, monopolization, pricing, product safety and vertical integration. He represents both US and international clients in civil, criminal and administrative matters.

Barry’s clients include publicly and privately held companies, trade associations and individuals. His clients conduct business in a variety of fields throughout the world including energy, financial services, health care, telecommunications, petrochemicals, pharmaceuticals, steel, avionics, plastics and consumer products.

Barry has been involved in some of the most significant cartel and international merger cases during the last decade. He has written and spoken extensively on all areas of competition law and regulatory enforcement.

Barry is a member of the Board of Advisers of The Antitrust Counselor, a periodical that reports on competition, trade regulation and compliance issues.

Principais Projetos

• Representing various French and Belgian persons in an international price fixing cartel investigation, US indictment and trial involving industrial diamonds.
• Representing a French conglomerate in the seriatim acquisitions of two of the three largest competitors in a specialty chemical market.
• Representing a Japan-based manufacturer of equipment used in the production of integrated circuits in the acquisition of a competitor located in the United States, involving the timely and successful completion of a second request from the US Department of Justice.
• Representing a US-based chemical company in the asset acquisition of five product lines from a German conglomerate where the assets purchased were located in 26 countries necessitating merger control filings in countries on five continents.
• Representing a large Europe-based phosphates manufacturer in negotiations with the FTC about the purchase of assets that were required to be divested as a condition to approving a merger transaction between two competitors.
• Representing a US-based automobile tire manufacturer in the formation of a strategic alliance with a tire company located in Europe.
• Representing a substantial manufacturer of athletic footwear in a resale price-maintenance investigation by the FTC.
• Representing a trade association in drafting and counseling with regard to a business review letter concerning the exchange of proprietary information necessary for the implementation of a program for the trading of equity securities in decimals.